Brian Takeo Smith and I are dusting off the archives from our seven-chapter Harvard neurotech IP that has only grown more relevant as our society explores the frontiers of human evolution

Last year, we sold HumanFirst, a company I co-founded to improve human flourishing, to ICON plc (NASDAQ: ICLR). I’ve stepped away from my operational role and entered a period of sabbatical. This transition offers an opportunity to share both published and unpublished notes from our early vision — these ideas have only grown more relevant as we advance toward AGI and enhanced human capabilities.

HumanFirst’s genesis traces back over a decade, rooted in my fascination with brain/mind connections and the potential for technology to advance human capabilities. While our commercial journey at HumanFirst focused on addressing a critical bottleneck in clinical trials — specifically, developing better evidence for endpoint measurement to de-risk and streamline the process — there was always a parallel vision that remained unexplored in the company.

One of my first memories exploring human potential happened freshman year at college. Every Duke freshman is required to take a class called WRITING20 — and the subtype I picked was on “Authenticity and Artifice”. At nineteen, I was captivated by a book called “Radical Evolution: The Promise and Peril of Enhancing Our Minds, Our Bodies” which chronicled the human enhancements that researchers like DARPA were making in hospitals and labs with our military members.

I explored what it was like to alter limbs, change mental acuity, and other capabilities that would make our species more advanced. While writing my capstone paper, I had no idea that I was already included in that set of augmented humans.

Authenticity and Artifice: Human augmentation hidden in plain sight

When I returned home for spring break my freshman year, my family shared with me that I was conceived via gamete intrafallopian transfer (GIFT). “You are a test tube baby. A GIFT baby,” said my mom. Until that day, I didn’t know that my very existence was a product of scientific innovation — a technological advancement that once existed beyond societal acceptance but has since become normalized.

Let’s look at the history: the first wave of research IVF resulted in a baby born in 1978, and by the time I was born in 1987, commercial assisted reproductive tech just started to become available. My mother told me that I was one of the first people in the country born via GIFT, which was a technological procedure available at the time to be a acceptable intervention within the Catholic church to overcome infertility (compared to ‘immoral’ IVF). Notably, this conversation is much less likely to happen today, as the Overton window has shifted.

This newfound knowledge rocked my whole world: I wasn’t a ‘naturally’ created human. From then on I fundamentally shifted the way I both relate to humans and consciousness. I realized human dignity trumps human authenticity. So, you could say I became an accidental pioneer of human potential from birth.

In 2015, nine years after that fateful WRITING20 class, I met Brian Takeo Smith, a grad school classmate who led teams overseas in the Navy’s Special Operations/Explosive Ordnance Disposal units. We teamed up for an independent project under professor Shikhar Ghosh to survey a range of players working on various aspects of brain advancements and human potential.

Our goal was to get a glimpse into the future — while sharing our learnings with the broader community. We outlined seven posts that would span across the science, funding, regulatory, and ethics of neurotech and human potential. We submitted our work for graduation, and had great ambitions to release our compendium to our broader community.

… and then I let this project sit in my drafts for nearly a decade.

This past weekend, I was inspired to ‘get current’ and realized I needed to release this writing out into the world. Continuing to wait was indulging my own more perfectionist tendencies. In the spirit of Jack Conte’s “Work to Publish” — hello world; here it is!

Brian and I took on this neurotech independent project (IP) in grad school because we believed then and it’s still clear to us now that the next few decades will be a defining moment for the human understanding of the brain and body. Humans are going to develop better ways to look at the brain — and also approaches to improve and repair it. Making such great strides in brain science is going to require many partners working together. Of course, we’ll have to understand the science, but we’ll also need to have the funding, a favorable regulatory environment, and a deep connection to humanity that allows innovation to flourish.

As we make scientific strides, we will have to face uncomfortable ethical questions. With any great technology advancement, we must be thoughtful about building the world that we want — and not an accidental one.

Here’s how we structured our NeuroTech IP:

Phase 1: The Scientific Journey

In this phase, Brian and I drafted four blog posts. The first post looked at the technologies that are being developed today to read the brain.

The next three posts were on emerging approaches to edit and repair the brain:

  1. Neuromodulation (e.g., stimulation of the brain)
  2. Optogenetics (e.g., controlling the brain with light)
  3. Digital medicine (e.g., software as medicine)

Phase 2: The Funding and Regulatory Environment

We believed — and still believe — one of the best ways to get a glimpse into the future is to understand the current financial incentives. In 2013, the White House launched a Grand Challenge called the BRAIN Initiative. We wrote this post on an overview of the initiative, and as of March 2025 the NIH shared an ground-breaking announcement on how the BRAIN Initiative has evolved, including research that was key to an FDA-approved personalized deep brain stimulation (DBS) product for Parkinson’s.

In 2018, a year after we completed our IP, I decided to dive deep into the regulatory environment by serving at the FDA in the Digital Health Unit as an Entrepreneur In Residence (more on the EIR role here). If you’re questioning your next career move, I highly recommend serving a ‘Tour of Duty’. Our government needs more folks like you.

Phase 3: Deep Dive on Neurotechnology and the US Military

Nuclear power, air travel, the internet, and numerous other scientific advances with great societal impact were born from military use-cases. In our write-up on neurotechnology initiatives and the military, we hypothesized that the more permissive research/testing/funding environment of the US military will be the first place that many of these advancements will be applied.

Phase 4: Ethics and Our Future

We wrapped up our work with a discussion on the ethical questions that came up during this research. Our goal for this section was to surface and explore the uncomfortable questions facing our society.

The Full List: Our NeuroTech Ventures Compendium

  1. You can (literally) turn on the lights using your mind — Matilda is not science fiction anymore (published in NeuroTechX, March 2017)
  2. Can stimulating your nervous system reverse Parkinson’s, reduce depressive episodes, and help you learn the piano? (published in NeuroTechX, March 2017)
  3. The Rise of Software as Medicine: Swapping out Pills for Apps, Algorithms, and Signals (published in WIRED, November 2018)
  4. Optogenetics-Controlling the Brain With Light (unpublished, in conversation with NeuroTechX)
  5. The BRAIN Initiative: The race to understand the human brain (published in NeuroTechX, April 2017)
  6. Applications: Neurotechnology and the US Military (unpublished, in conversation with NeuroTechX)
  7. The Evolution of the Human Brain: The Past, The New, and Our Future (written in 2017, published in 2025)

After we graduated, I co-founded HumanFirst, guided by a consistent vision: to use technology to expand human potential while addressing real-world healthcare challenges. HumanFirst’s flagship platform, Atlas, eventually cataloged over 3,000 technologies and 15,000 digital measures, resulting in 25+ ontologies that emerged through advances in AI/ML — and 24 of the top 25 pharma companies used Atlas by the time we merged HumanFirst into ICON’s outcome measures service.

That growth continued to accelerate: by 2024, over 130 pharma and biotech organizations had relied on AI-powered digital biomarkers and sensor-derived clinical outcome assessments (COAs) to capture patient-centered endpoints.

Our focus at HumanFirst enabled our product’s success, and at the same time, we had to leave some promising early concepts unexplored. After I left HumanFirst and got a break from operating, I wanted to openly publish our early vision and flag a couple of neurotech pathways that we didn’t have the capacity to commercialize (like this one). My hope is that our compendium can serve as an open foundation for folks to build upon — and as an invitation to collaborate as I re-emerge post-sabbatical.

As society stands at the cusp of transformative advances in intelligence and human experience, I’m opening these archived notes that remain remarkably prescient. At its core the AI race towards AGI, and ultimately ASI, is a race for intelligence, and I believe that we will need to build thoughtfully technologies for our brain/mind, specifically neurotechnologies, to integrate these AI advancements together with human ones.

The seven articles listed above comprise our The Neurotech Compendium — insights from nearly a decade ago that have only grown in relevance as we continue to explore the frontier of human-machine integration and cognitive enhancement.

Acknowledgments

I’d like to share a big thank you to the team at NeuroTechX, who collaborated and published many of our pieces. To Shikar Ghosh who was our faculty sponsor of this project and Brian (@TakeoSmith) my co-conspirator on this IP. Big thanks to Adam Conner-Simons and Dan Goodwin for reviewing the pieces, and to Jess Cole, Ginny Fahs, Rachel Katz, Linda Xie and John Weldon who inspired me to resurrect this project out of my drafts and ship it!

To follow our work and future posts, you can find me on Bluesky, Farcaster, X (@andreacoravos) and Google Scholar. Would love to connect with fellow researchers, entrepreneurs, and enthusiasts working at the intersection of the brain, mind, and human flourishing.

Sofia, Andy, and Brian (2017) working on prototypes in grad school that would eventually become HumanFirst.

<hr><p>The Neurotech Compendium: Reflections from the Frontier was originally published in Andrea’s Blog on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>